New pill takes aim at Hard-to-Treat blood cancers
NCT ID NCT05753501
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 9 times
Summary
This early study tests a new drug called ABBV-101 in people with several types of non-Hodgkin lymphoma that have come back or not responded to other treatments. The drug is a pill that targets a protein (BTK) involved in cancer growth. The main goals are to find a safe dose and see if it can shrink tumors. About 135 adults will take part worldwide.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ABBV-101 (a BTK degrader drug taken by mouth)
- What this could lead to
- If this works, it could offer a new treatment option for people with certain blood cancers that have not responded to other therapies.
- What could go wrong
- This is a very early (first-in-human) study, so safety and effectiveness are not yet known. It may not work or could have unexpected side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO - Ospedale Molinette /ID# 253530
Turin, Piedmont, 10126, Italy
-
ASST Grande Ospedale Metropolitano Niguarda /ID# 253532
Milan, Milano, 20162, Italy
-
Addenbrookes Hospital /ID# 256242
Cambridge, Cambridgeshire, CB2 2QQ, United Kingdom
-
Arizona Oncology - Tucson - Wilmot Road /ID# 252351
Tucson, Arizona, 85711, United States
-
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII /ID# 260317
Bergamo, 24127, Italy
-
Beth Israel Deaconess Medical Center /ID# 249302
Boston, Massachusetts, 02215-5400, United States
-
CHRU Lille - Hopital Claude Huriez /ID# 253665
Lille, Nord, 59037, France
-
CHU Montpellier - Hopital Saint Eloi /ID# 253666
Montpellier, Herault, 34295, France
-
CHUM Notre-Dame Hospital /ID# 253428
Montreal, Quebec, H2L 4M1, Canada
-
Centre Hospitalier Universitaire de Nantes, Hotel Dieu -HME /ID# 256248
Nantes, Pays de la Loire Region, 44000, France
-
Charite Universitaetsklinikum Berlin - Campus Benjamin Franklin /ID# 257431
Berlin, 12203, Germany
-
Hadassah Medical Center-Hebrew University /ID# 251123
Jerusalem, Jerusalem, 91120, Israel
-
Hopital Saint-Louis /ID# 253663
Paris, 75010, France
-
Hospital Universitario Fundacion Jimenez Diaz /ID# 253654
Madrid, 28040, Spain
-
Hospital Universitario HM Sanchinarro /ID# 253655
Madrid, 28050, Spain
-
Hospital Universitario Puerta de Hierro - Majadahonda /ID# 260196
Majadahonda, Madrid, 28222, Spain
-
Hospital Universitario Ramon y Cajal /ID# 260450
Madrid, 28034, Spain
-
Hospital Universitario Vall de Hebron /ID# 260447
Barcelona, 08035, Spain
-
Hospital Universitario de Salamanca /ID# 253656
Salamanca, 37711, Spain
-
IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 255172
Bologna, 40138, Italy
-
IRCCS Ospedale San Raffaele /ID# 253531
Milan, Milano, 20132, Italy
-
Institut Bergonie /ID# 253664
Bordeaux, Gironde, 33000, France
-
Institut Gustave Roussy /ID# 253662
Villejuif, Val-de-Marne, 94805, France
-
Kings College Hospital NHS Foundation Trust /ID# 253670
London, Greater London, SE5 9RS, United Kingdom
-
Kyoto University Hospital /ID# 261837
Kyoto, Kyoto, 606-8507, Japan
-
Leicester Royal Infirmary /ID# 255171
Leicester, England, LE1 5WW, United Kingdom
-
MD Anderson Cancer Center /ID# 249293
Houston, Texas, 77030, United States
-
National Cancer Center Hospital /ID# 250680
Chuo-ku, Tokyo, 104-0045, Japan
-
National Cancer Center Hospital East /ID# 250684
Kashiwa-shi, Chiba, 277-8577, Japan
-
New York Oncology Hematology - Albany Cancer Center /ID# 252240
Albany, New York, 12206-5013, United States
-
Northwell Health - Monter Cancer Center /ID# 250422
Lake Success, New York, 11042, United States
-
Northwestern University Feinberg School of Medicine /ID# 249347
Chicago, Illinois, 60611-2927, United States
-
Oncology Assoc. of Oregon PC - WVCI and Research Ctr - Springfield /ID# 249309
Eugene, Oregon, 97401-6036, United States
-
Rocky Mountain Cancer Centers - Lone Tree /ID# 252237
Lone Tree, Colorado, 80124, United States
-
Rutgers Cancer Institute of New Jersey /ID# 249323
New Brunswick, New Jersey, 08901, United States
-
Stanford University - Palo Alto /ID# 249683
Palo Alto, California, 94304, United States
-
Tel Aviv Sourasky Medical Center /ID# 259608
Tel Aviv, Tel Aviv, 6423906, Israel
-
The Cancer Institute Hospital Of JFCR /ID# 260375
Koto-ku, Tokyo, 135-8550, Japan
-
The Chaim Sheba Medical Center /ID# 251122
Ramat Gan, Tel Aviv, 5265601, Israel
-
UC Health - Cincinnati /ID# 249299
Cincinnati, Ohio, 45267-2800, United States
-
UC Irvine Medical Center /ID# 263020
Orange, California, 92868-3201, United States
-
Universitaetsklinikum Hamburg-Eppendorf /ID# 264566
Hamburg, 20246, Germany
-
Universitaetsklinikum Ulm /ID# 253742
Ulm, Baden-Wurttemberg, 89081, Germany
-
Universitaetsklinikum Wuerzburg /ID# 254636
Würzburg, Bavaria, 97080, Germany
-
Universitaetsklinikum des Saarlandes /ID# 257435
Homburg, Saarland, 66424, Germany
-
Universitaetsmedizin Rostock /ID# 259657
Rostock, Mecklenburg-Vorpommern, 18057, Germany
-
University College London Hospital /ID# 260202
London, Greater London, NW1 2BU, United Kingdom
-
University Health Network_Princess Margaret Cancer Centre /ID# 253483
Toronto, Ontario, M5G 2M9, Canada
-
University of Pennsylvania /ID# 250341
Philadelphia, Pennsylvania, 19104, United States
-
University of Rochester Medical Center /ID# 249324
Rochester, New York, 14642-0001, United States
-
Yitzhak Shamir Medical Center /ID# 254566
Ẕerifin, Central District, 70300, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- Can an immune booster outsmart brain lymphoma?
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Can a Triple-Drug combo wipe out Slow-Growing lymphomas?
- Engineered immune cells take aim at Hard-to-Treat lymphomas
- Can donor immune cells be engineered to fight blood cancer?